A Randomized Comparison of Acitretin-narrow-band TL-01 Phototherapy and Acitretin-Psoralen plus Ultraviolet A for Psoriasis
dc.contributor.author | Oezemir, Mustafa | |
dc.contributor.author | Engin, Burhan | |
dc.contributor.author | Baysal, Ibrahim | |
dc.contributor.author | Mevlitoglu, Inci | |
dc.date.accessioned | 2020-03-26T17:26:21Z | |
dc.date.available | 2020-03-26T17:26:21Z | |
dc.date.issued | 2008 | |
dc.department | Selçuk Üniversitesi | en_US |
dc.description.abstract | The combination of retinoids with phototherapy enhances the efficacy of phototherapy and reduces the cumulative ultraviolet dose and duration of the therapy needed to treat chronic plaque psoriasis. Although TL-01 phototherapy has been used widely, there are few data about the effectiveness of the combination of acitretin with TL-01 in treatment of the disease. The aim of this study was to compare acitretin-narrow-band TL-01 phototherapy with acitretin-psoralen plus ultraviolet A (acitretin-PUVA) in psoriasis. We studied 60 patients with moderate to severe plaque psoriasis who were randomly allocated to three times weekly treatment acitretin-narrow-band TL-01 or acitretin-PUVA. The efficacy of treatments was assessed using the Psoriasis Area and Severity Index by a blinded observer. Clearance of psoriasis was achieved in 56.6% of patients treated with acitretin-narrow-band TL-01 and in 63.3% of those treated with acitretin-PUVA. All of these patients remained clear of psoriasis 3 months after finishing the treatments. Mucocutaneous side-effects, such as dry lips and mouth, were the most common complaints in both groups. In conclusion, acitretin-narrow-band TL-01 is an effective and well-tolerated treatment for moderate to severe plaque psoriasis, with a therapeutic effect equal to that of acitretin-PUVA. | en_US |
dc.identifier.doi | 10.2340/00015555-0529 | en_US |
dc.identifier.endpage | 593 | en_US |
dc.identifier.issn | 0001-5555 | en_US |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 19002344 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 589 | en_US |
dc.identifier.uri | https://dx.doi.org/10.2340/00015555-0529 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/22173 | |
dc.identifier.volume | 88 | en_US |
dc.identifier.wos | WOS:000261098300008 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | ACTA DERMATO-VENEREOLOGICA | en_US |
dc.relation.ispartof | ACTA DERMATO-VENEREOLOGICA | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.subject | phototherapy | en_US |
dc.subject | psoriasis | en_US |
dc.subject | retinoid | en_US |
dc.subject | re-TL-01 | en_US |
dc.subject | re-PUVA | en_US |
dc.title | A Randomized Comparison of Acitretin-narrow-band TL-01 Phototherapy and Acitretin-Psoralen plus Ultraviolet A for Psoriasis | en_US |
dc.type | Article | en_US |